NCT02668237 - Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAP | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

June 9, 2016

Primary Completion Date

December 28, 2018

Study Completion Date

January 14, 2019

Conditions

Community-Acquired Pneumonia

Interventions

OTHER

OptiPAC

Molecular and urinary tests.

OTHER

Usual care

Antibiotics for prevention.

Trial Locations (11)

Chu Marseille, Marseille

Chu Brest, Brest

Chu Toulouse, Toulouse

Chu Grenoble, Grenoble

Chu Saint Etienne, Saint-Etienne

Chu Reims, Reims

Chu Estaing, Clermont-Ferrand

Chu Strasbourg, Strasbourg

CHU CAEN, Caen

APHP - Béclère, Paris

APHP - Necker, Paris